The K@W Network:
President Trump’s recently announced plan to lower prescription drug prices could benefit consumers in the short run, but it may end up hurting new drug development, experts say.
A possible breakthrough in the Golden State Killer case thanks to DNA samples from a genealogical testing service has prompted calls for stricter protection of personal genetic data.
Insurers’ inability to recover their dues under an Affordable Care Act risk-sharing program is not only impacting those companies but also causing collateral damage in the marketplace, say experts.
The three heavyweights announced last week that they are joining forces to reduce health care costs for their employees. Will the new model shake up the health care industry?
Other brands can learn important lessons from Procter & Gamble's response to the trend of teenage YouTubers ingesting toxic detergent pods.